{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T05:09:35Z","timestamp":1777698575321,"version":"3.51.4"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["NO. LZ2016002"],"award-info":[{"award-number":["NO. LZ2016002"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cancer pain is the most prevalent symptom experienced by cancer patients. It substantially impacts a patient\u2019s long-term physical and emotional health, making it a pressing issue that must be addressed. Purinergic receptor P2X7 (P2X7R) is a widely distributed and potent non-selective ATP-gated ion channel that regulates tumor proliferation, chronic pain, and the formation of inflammatory lesions in the central nervous system. P2X7R plays an essential role in cancer pain and complications related to cancer pain including depression and opioid tolerance. This review focuses on the structure and distribution of P2X7R, its role in diverse tissues in cancer pain, and the application of P2X7R antagonists in the treatment of cancer pain to propose new ideas for cancer pain management.<\/jats:p>","DOI":"10.1007\/s11302-022-09902-1","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T04:35:27Z","timestamp":1668832527000},"page":"441-450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Emerging roles of the P2X7 receptor in cancer pain"],"prefix":"10.1007","volume":"19","author":[{"given":"Ping","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yansong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"6","key":"9902_CR1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3322\/caac.21577","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Miller KD, Dale W, Mohile SG, Cohen HJ, Leach CR, Goding Sauer A, Jemal A, Siegel RL (2019) Cancer statistics for adults aged 85 years and older. CA Cancer J Clin 69(6):452\u2013467. https:\/\/doi.org\/10.3322\/caac.21577","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"9902_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MH van den Beuken-van Everdingen","year":"2016","unstructured":"van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ (2016) Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage 51(6):1070-1090 e1079. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.340","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"9902_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0304-3959(95)00017-M","volume":"63","author":"DFJ Zech","year":"1995","unstructured":"Zech DFJ, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 63(1):65\u201376. https:\/\/doi.org\/10.1016\/0304-3959(95)00017-M","journal-title":"Pain"},{"issue":"9","key":"9902_CR4","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","volume":"18","author":"MH van den Beuken-van Everdingen","year":"2007","unstructured":"van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18(9):1437\u20131449. https:\/\/doi.org\/10.1093\/annonc\/mdm056","journal-title":"Ann Oncol"},{"key":"9902_CR5","doi-asserted-by":"publisher","first-page":"h315","DOI":"10.1136\/bmj.h315","volume":"350","author":"CM Kane","year":"2015","unstructured":"Kane CM, Hoskin P, Bennett MI (2015) Cancer induced bone pain. BMJ 350:h315. https:\/\/doi.org\/10.1136\/bmj.h315","journal-title":"BMJ"},{"key":"9902_CR6","doi-asserted-by":"publisher","first-page":"5093095","DOI":"10.1155\/2016\/5093095","volume":"2016","author":"G Zhu","year":"2016","unstructured":"Zhu G, Dong Y, He X, Zhao P, Yang A, Zhou R, Ma J, Xie Z, Song XJ (2016) Radiotherapy suppresses bone cancer pain through inhibiting activation of cAMP signaling in rat dorsal root ganglion and spinal cord. Mediators Inflamm 2016:5093095. https:\/\/doi.org\/10.1155\/2016\/5093095","journal-title":"Mediators Inflamm"},{"issue":"46","key":"9902_CR7","doi-asserted-by":"publisher","first-page":"14415","DOI":"10.1523\/JNEUROSCI.4569-09.2009","volume":"29","author":"M Costigan","year":"2009","unstructured":"Costigan M, Moss A, Latremoliere A, Johnston C, Verma-Gandhu M, Herbert TA, Barrett L, Brenner GJ, Vardeh D, Woolf CJ et al (2009) T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci 29(46):14415\u201314422. https:\/\/doi.org\/10.1523\/JNEUROSCI.4569-09.2009","journal-title":"J Neurosci"},{"issue":"6312","key":"9902_CR8","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaf8924","volume":"354","author":"RR Ji","year":"2016","unstructured":"Ji RR, Chamessian A, Zhang YQ (2016) Pain regulation by non-neuronal cells and inflammation. Science 354(6312):572\u2013577. https:\/\/doi.org\/10.1126\/science.aaf8924","journal-title":"Science"},{"key":"9902_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2018.12.032","volume":"845","author":"S Falk","year":"2019","unstructured":"Falk S, Appel CK, Bennedbaek HB, Al-Dihaissy T, Unger A, Dinkel K, Heegaard AM (2019) Chronic high dose P2X7 receptor inhibition exacerbates cancer-induced bone pain. Eur J Pharmacol 845:48\u201355. https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.032","journal-title":"Eur J Pharmacol"},{"issue":"20","key":"9902_CR10","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1523\/JNEUROSCI.5250-14.2015","volume":"35","author":"Y Yang","year":"2015","unstructured":"Yang Y, Li H, Li TT, Luo H, Gu XY, Lu N, Ji RR, Zhang YQ (2015) Delayed activation of spinal microglia contributes to the maintenance of bone cancer pain in female Wistar rats via P2X7 receptor and IL-18. J Neurosci 35(20):7950\u20137963. https:\/\/doi.org\/10.1523\/JNEUROSCI.5250-14.2015","journal-title":"J Neurosci"},{"key":"9902_CR11","doi-asserted-by":"publisher","first-page":"27512","DOI":"10.1038\/srep27512","volume":"6","author":"Y Xu","year":"2016","unstructured":"Xu Y, Liu J, He M, Liu R, Belegu V, Dai P, Liu W, Wang W, Xia QJ, Shang FF et al (2016) Mechanisms of PDGF siRNA-mediated inhibition of bone cancer pain in the spinal cord. Sci Rep 6:27512. https:\/\/doi.org\/10.1038\/srep27512","journal-title":"Sci Rep"},{"issue":"12","key":"9902_CR12","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1002\/pon.4883","volume":"27","author":"K Kwekkeboom","year":"2018","unstructured":"Kwekkeboom K, Zhang Y, Campbell T, Coe CL, Costanzo E, Serlin RC, Ward S (2018) Randomized controlled trial of a brief cognitive-behavioral strategies intervention for the pain, fatigue, and sleep disturbance symptom cluster in advanced cancer. Psychooncology 27(12):2761\u20132769. https:\/\/doi.org\/10.1002\/pon.4883","journal-title":"Psychooncology"},{"issue":"16","key":"9902_CR13","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1523\/JNEUROSCI.20-16-05965.2000","volume":"20","author":"T Pannicke","year":"2000","unstructured":"Pannicke T, Fischer W, Biedermann B, Schadlich H, Grosche J, Faude F, Wiedemann P, Allgaier C, Illes P, Burnstock G et al (2000) P2X7 receptors in Muller glial cells from the human retina. J Neurosci 20(16):5965\u20135972","journal-title":"J Neurosci"},{"issue":"3","key":"9902_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/bph.15299","volume":"178","author":"P Illes","year":"2021","unstructured":"Illes P, Muller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS et al (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 178(3):489\u2013514. https:\/\/doi.org\/10.1111\/bph.15299","journal-title":"Br J Pharmacol"},{"issue":"7","key":"9902_CR15","doi-asserted-by":"publisher","first-page":"e2599","DOI":"10.1371\/journal.pone.0002599","volume":"3","author":"P Pellegatti","year":"2008","unstructured":"Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3(7):e2599. https:\/\/doi.org\/10.1371\/journal.pone.0002599","journal-title":"PLoS One"},{"issue":"3","key":"9902_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/jnr.20475","volume":"81","author":"JG McLarnon","year":"2005","unstructured":"McLarnon JG (2005) Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP. J Neurosci Res 81(3):349\u2013356. https:\/\/doi.org\/10.1002\/jnr.20475","journal-title":"J Neurosci Res"},{"issue":"12","key":"9902_CR17","doi-asserted-by":"publisher","first-page":"7930","DOI":"10.1074\/jbc.M114.627810","volume":"290","author":"X Liang","year":"2015","unstructured":"Liang X, Samways DS, Wolf K, Bowles EA, Richards JP, Bruno J, Dutertre S, DiPaolo RJ, Egan TM (2015) Quantifying Ca2+ current and permeability in ATP-gated P2X7 receptors. J Biol Chem 290(12):7930\u20137942. https:\/\/doi.org\/10.1074\/jbc.M114.627810","journal-title":"J Biol Chem"},{"key":"9902_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fnmol.2019.00183","volume":"12","author":"R Kopp","year":"2019","unstructured":"Kopp R, Krautloher A, Ramirez-Fernandez A, Nicke A (2019) P2X7 interactions and signaling - making head or tail of it. Front Mol Neurosci 12:183. https:\/\/doi.org\/10.3389\/fnmol.2019.00183","journal-title":"Front Mol Neurosci"},{"key":"9902_CR19","doi-asserted-by":"publisher","unstructured":"He X, Wan J, Yang X, Zhang X, Huang D, Li X, Zou Y, Chen C, Yu Z, Xie L et al (2021) Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models. J Clin Invest 131(4):https:\/\/doi.org\/10.1172\/JCI140242","DOI":"10.1172\/JCI140242"},{"key":"9902_CR20","doi-asserted-by":"publisher","unstructured":"Illes P, Rubini P, Ulrich H, Zhao Y, Tang Y (2020) Regulation of microglial functions by purinergic mechanisms in the healthy and diseased CNS. Cells 9(5):https:\/\/doi.org\/10.3390\/cells9051108","DOI":"10.3390\/cells9051108"},{"issue":"8","key":"9902_CR21","doi-asserted-by":"publisher","first-page":"e0183688","DOI":"10.1371\/journal.pone.0183688","volume":"12","author":"Q Chen","year":"2017","unstructured":"Chen Q, Wu H, Tao J, Liu C, Deng Z, Liu Y, Chen G, Liu B, Xu C (2017) Effect of naringin on gp120-induced injury mediated by P2X7 receptors in rat primary cultured microglia. PLoS One 12(8):e0183688. https:\/\/doi.org\/10.1371\/journal.pone.0183688","journal-title":"PLoS One"},{"issue":"6","key":"9902_CR22","doi-asserted-by":"publisher","first-page":"e100282","DOI":"10.1371\/journal.pone.0100282","volume":"9","author":"G Ebeling","year":"2014","unstructured":"Ebeling G, Blasche R, Hofmann F, Augstein A, Kasper M, Barth K (2014) Effect of P2X7 receptor knockout on AQP-5 expression of type I alveolar epithelial cells. PLoS One 9(6):e100282. https:\/\/doi.org\/10.1371\/journal.pone.0100282","journal-title":"PLoS One"},{"issue":"1","key":"9902_CR23","doi-asserted-by":"publisher","first-page":"e29990","DOI":"10.1371\/journal.pone.0029990","volume":"7","author":"KA Vessey","year":"2012","unstructured":"Vessey KA, Fletcher EL (2012) Rod and cone pathway signalling is altered in the P2X7 receptor knock out mouse. PLoS One 7(1):e29990. https:\/\/doi.org\/10.1371\/journal.pone.0029990","journal-title":"PLoS One"},{"key":"9902_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.exer.2014.08.009","volume":"127","author":"J Sanderson","year":"2014","unstructured":"Sanderson J, Dartt DA, Trinkaus-Randall V, Pintor J, Civan MM, Delamere NA, Fletcher EL, Salt TE, Grosche A, Mitchell CH (2014) Purines in the eye: recent evidence for the physiological and pathological role of purines in the RPE, retinal neurons, astrocytes, Muller cells, lens, trabecular meshwork, cornea and lacrimal gland. Exp Eye Res 127:270\u2013279. https:\/\/doi.org\/10.1016\/j.exer.2014.08.009","journal-title":"Exp Eye Res"},{"issue":"Pt B","key":"9902_CR25","doi-asserted-by":"publisher","first-page":"108314","DOI":"10.1016\/j.intimp.2021.108314","volume":"101","author":"Z Lu","year":"2021","unstructured":"Lu Z, Yao Y, Wang J, Peng JY (2021) Dioscin ameliorates diabetes cognitive dysfunction via adjusting P2X7R\/NLRP3 signal. Int Immunopharmacol 101(Pt B):108314. https:\/\/doi.org\/10.1016\/j.intimp.2021.108314","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"9902_CR26","doi-asserted-by":"publisher","first-page":"e0252334","DOI":"10.1371\/journal.pone.0252334","volume":"16","author":"J Zhang","year":"2021","unstructured":"Zhang J, Wang XJ, Wu LJ, Yang L, Yang YT, Zhang D, Hong J, Li XY, Dong XQ, Guo XC et al (2021) Herb-partitioned moxibustion alleviates colonic inflammation in Crohn\u2019s disease rats by inhibiting hyperactivation of the NLRP3 inflammasome via regulation of the P2X7R-Pannexin-1 signaling pathway. PLoS One 16(5):e0252334. https:\/\/doi.org\/10.1371\/journal.pone.0252334","journal-title":"PLoS One"},{"issue":"1","key":"9902_CR27","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12974-017-0865-y","volume":"14","author":"N Yue","year":"2017","unstructured":"Yue N, Huang H, Zhu X, Han Q, Wang Y, Li B, Liu Q, Wu G, Zhang Y, Yu J (2017) Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors. J Neuroinflammation 14(1):102. https:\/\/doi.org\/10.1186\/s12974-017-0865-y","journal-title":"J Neuroinflammation"},{"key":"9902_CR28","doi-asserted-by":"publisher","first-page":"174480692199765","DOI":"10.1177\/1744806921997654","volume":"17","author":"Q Wu","year":"2021","unstructured":"Wu Q, Yue J, Lin L, Yu X, Zhou Y, Ying X, Chen X, Tu W, Lou X, Yang G et al (2021) Electroacupuncture may alleviate neuropathic pain via suppressing P2X7R expression. Mol Pain 17:1744806921997654. https:\/\/doi.org\/10.1177\/1744806921997654","journal-title":"Mol Pain"},{"key":"9902_CR29","doi-asserted-by":"publisher","unstructured":"Illes P (2020) P2X7 receptors amplify CNS damage in neurodegenerative diseases. Int J Mol Sci 21(17):https:\/\/doi.org\/10.3390\/ijms21175996","DOI":"10.3390\/ijms21175996"},{"issue":"2","key":"9902_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11302-021-09776-9","volume":"17","author":"M Drill","year":"2021","unstructured":"Drill M, Jones NC, Hunn M, O\u2019Brien TJ, Monif M (2021) Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer. Purinergic Signal 17(2):215\u2013227. https:\/\/doi.org\/10.1007\/s11302-021-09776-9","journal-title":"Purinergic Signal"},{"key":"9902_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fnins.2015.00148","volume":"9","author":"RJ Rodrigues","year":"2015","unstructured":"Rodrigues RJ, Tome AR, Cunha RA (2015) ATP as a multi-target danger signal in the brain. Front Neurosci 9:148. https:\/\/doi.org\/10.3389\/fnins.2015.00148","journal-title":"Front Neurosci"},{"issue":"8","key":"9902_CR32","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1096\/fj.09-150862","volume":"24","author":"L Stokes","year":"2010","unstructured":"Stokes L, Fuller SJ, Sluyter R, Skarratt KK, Gu BJ, Wiley JS (2010) Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion. FASEB J 24(8):2916\u20132927. https:\/\/doi.org\/10.1096\/fj.09-150862","journal-title":"FASEB J"},{"issue":"6","key":"9902_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1097\/j.pain.0000000000001188","volume":"159","author":"O Kambur","year":"2018","unstructured":"Kambur O, Kaunisto MA, Winsvold BS, Wilsgaard T, Stubhaug A, Zwart JA, Kalso E, Nielsen CS (2018) Genetic variation in P2RX7 and pain tolerance. Pain 159(6):1064\u20131073. https:\/\/doi.org\/10.1097\/j.pain.0000000000001188","journal-title":"Pain"},{"issue":"8","key":"9902_CR34","doi-asserted-by":"publisher","first-page":"e0181685","DOI":"10.1371\/journal.pone.0181685","volume":"12","author":"JH Tao","year":"2017","unstructured":"Tao JH, Cheng M, Tang JP, Dai XJ, Zhang Y, Li XP, Liu Q, Wang YL (2017) Single nucleotide polymorphisms associated with P2X7R function regulate the onset of gouty arthritis. PLoS One 12(8):e0181685. https:\/\/doi.org\/10.1371\/journal.pone.0181685","journal-title":"PLoS One"},{"issue":"3","key":"9902_CR35","first-page":"E281","volume":"23","author":"X Xing","year":"2020","unstructured":"Xing X, Bai Y, Sun K, Chen Q, Huang H, Qiu W, Yan M (2020) Identification of candidate genes associated with postherpetic neuralgia susceptibility. Pain Physician 23(3):E281\u2013E288","journal-title":"Pain Physician"},{"issue":"8","key":"9902_CR36","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.pain.2011.03.024","volume":"152","author":"RR Hansen","year":"2011","unstructured":"Hansen RR, Nielsen CK, Nasser A, Thomsen SIM, Eghorn LF, Pham Y, Schulenburg C, Syberg S, Ding M, Stojilkovic SS et al (2011) P2X7 receptor-deficient mice are susceptible to bone cancer pain. Pain 152(8):1766\u20131776. https:\/\/doi.org\/10.1016\/j.pain.2011.03.024","journal-title":"Pain"},{"issue":"3","key":"9902_CR37","first-page":"224","volume":"68","author":"X Zhao","year":"2016","unstructured":"Zhao X, Liu HZ, Zhang YQ (2016) Effect of P2X7 receptor knock-out on bone cancer pain in mice. Sheng Li Xue Bao 68(3):224\u2013232","journal-title":"Sheng Li Xue Bao"},{"issue":"20","key":"9902_CR38","doi-asserted-by":"publisher","first-page":"9426","DOI":"10.1158\/0008-5472.CAN-05-0826","volume":"65","author":"KG Halvorson","year":"2005","unstructured":"Halvorson KG, Kubota K, Sevcik MA, Lindsay TH, Sotillo JE, Ghilardi JR, Rosol TJ, Boustany L, Shelton DL, Mantyh PW (2005) A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res 65(20):9426\u20139435. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0826","journal-title":"Cancer Res"},{"issue":"11","key":"9902_CR39","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1158\/2326-6066.CIR-20-0123","volume":"8","author":"J Qin","year":"2020","unstructured":"Qin J, Zhang X, Tan B, Zhang S, Yin C, Xue Q, Zhang Z, Ren H, Chen J, Liu M et al (2020) Blocking P2X7-mediated macrophage polarization overcomes treatment resistance in lung cancer. Cancer Immunol Res 8(11):1426\u20131439. https:\/\/doi.org\/10.1158\/2326-6066.CIR-20-0123","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"9902_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1249\/MSS.0000000000001411","volume":"50","author":"J Tian","year":"2018","unstructured":"Tian J, Yu T, Xu Y, Pu S, Lv Y, Zhang X, Du D (2018) Swimming training reduces neuroma pain by regulating neurotrophins. Med Sci Sports Exerc 50(1):54\u201361. https:\/\/doi.org\/10.1249\/MSS.0000000000001411","journal-title":"Med Sci Sports Exerc"},{"issue":"10","key":"9902_CR41","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","volume":"18","author":"F Di Virgilio","year":"2018","unstructured":"Di Virgilio F, Sarti AC, Falzoni S, De Marchi E, Adinolfi E (2018) Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer 18(10):601\u2013618. https:\/\/doi.org\/10.1038\/s41568-018-0037-0","journal-title":"Nat Rev Cancer"},{"key":"9902_CR42","doi-asserted-by":"publisher","first-page":"174480692110609","DOI":"10.1177\/17448069211060962","volume":"18","author":"P Wu","year":"2022","unstructured":"Wu P, Zhou G, Wu X, Lv R, Yao J, Wen Q (2022) P2X7 receptor induces microglia polarization to the M1 phenotype in cancer-induced bone pain rat models. Mol Pain 18:17448069211060962. https:\/\/doi.org\/10.1177\/17448069211060962","journal-title":"Mol Pain"},{"issue":"1","key":"9902_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3892\/or.2015.3979","volume":"34","author":"J Xia","year":"2015","unstructured":"Xia J, Yu X, Tang L, Li G, He T (2015) P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway. Oncol Rep 34(1):103\u2013110. https:\/\/doi.org\/10.3892\/or.2015.3979","journal-title":"Oncol Rep"},{"key":"9902_CR44","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuropharm.2015.05.037","volume":"97","author":"ML Di Cesare","year":"2015","unstructured":"Di Cesare ML, Marcoli M, Micheli L, Zanardelli M, Maura G, Ghelardini C, Cervetto C (2015) Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1. Neuropharmacology 97:133\u2013141. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.05.037","journal-title":"Neuropharmacology"},{"issue":"10","key":"9902_CR45","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.immuni.2021.09.014","volume":"54","author":"K Borst","year":"2021","unstructured":"Borst K, Dumas AA, Prinz M (2021) Microglia: immune and non-immune functions. Immunity 54(10):2194\u20132208. https:\/\/doi.org\/10.1016\/j.immuni.2021.09.014","journal-title":"Immunity"},{"issue":"10","key":"9902_CR46","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","volume":"35","author":"B Sperlagh","year":"2014","unstructured":"Sperlagh B, Illes P (2014) P2X7 receptor: an emerging target in central nervous system diseases. Trends Pharmacol Sci 35(10):537\u2013547. https:\/\/doi.org\/10.1016\/j.tips.2014.08.002","journal-title":"Trends Pharmacol Sci"},{"key":"9902_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13578-020-00405-3","volume":"10","author":"X Gui","year":"2020","unstructured":"Gui X, Wang H, Wu L, Tian S, Wang X, Zheng H, Wu W (2020) Botulinum toxin type A promotes microglial M2 polarization and suppresses chronic constriction injury-induced neuropathic pain through the P2X7 receptor. Cell Biosci 10:45. https:\/\/doi.org\/10.1186\/s13578-020-00405-3","journal-title":"Cell Biosci"},{"issue":"1","key":"9902_CR48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11302-021-09796-5","volume":"18","author":"WJ Ren","year":"2022","unstructured":"Ren WJ, Illes P (2022) Involvement of P2X7 receptors in chronic pain disorders. Purinergic Signal 18(1):83\u201392. https:\/\/doi.org\/10.1007\/s11302-021-09796-5","journal-title":"Purinergic Signal"},{"key":"9902_CR49","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuroscience.2015.02.011","volume":"291","author":"S Falk","year":"2015","unstructured":"Falk S, Schwab SD, Frosig-Jorgensen M, Clausen RP, Dickenson AH, Heegaard AM (2015) P2X7 receptor-mediated analgesia in cancer-induced bone pain. Neuroscience 291:93\u2013105. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.02.011","journal-title":"Neuroscience"},{"issue":"2","key":"9902_CR50","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.pain.2013.10.008","volume":"155","author":"VRR Ducourneau","year":"2014","unstructured":"Ducourneau VRR, Dolique T, Hachem-Delaunay S, Miraucourt LS, Amadio A, Blaszczyk L, Jacquot F, Ly J, Devoize L, Oliet SHR et al (2014) Cancer pain is not necessarily correlated with spinal overexpression of reactive glia markers. Pain 155(2):275\u2013291. https:\/\/doi.org\/10.1016\/j.pain.2013.10.008","journal-title":"Pain"},{"key":"9902_CR51","doi-asserted-by":"publisher","first-page":"9724371","DOI":"10.1155\/2017\/9724371","volume":"2017","author":"J Sheng","year":"2017","unstructured":"Sheng J, Liu S, Wang Y, Cui R, Zhang X (2017) The link between depression and chronic pain: neural mechanisms in the brain. Neural Plast 2017:9724371. https:\/\/doi.org\/10.1155\/2017\/9724371","journal-title":"Neural Plast"},{"issue":"7","key":"9902_CR52","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/00325481.2019.1663705","volume":"131","author":"A Michaelides","year":"2019","unstructured":"Michaelides A, Zis P (2019) Depression, anxiety and acute pain: links and management challenges. Postgrad Med 131(7):438\u2013444. https:\/\/doi.org\/10.1080\/00325481.2019.1663705","journal-title":"Postgrad Med"},{"key":"9902_CR53","doi-asserted-by":"publisher","first-page":"5515629","DOI":"10.1155\/2021\/5515629","volume":"2021","author":"M Brinkers","year":"2021","unstructured":"Brinkers M, Pfau G, Toepffer AM, Meyer F, Kretzschmar MA (2021) The incidence of mental disorders increases over time in patients with cancer pain: data from a retrospective cohort study. Pain Res Manag 2021:5515629. https:\/\/doi.org\/10.1155\/2021\/5515629","journal-title":"Pain Res Manag"},{"issue":"4","key":"9902_CR54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ajmg.b.30303","volume":"141B","author":"N Barden","year":"2006","unstructured":"Barden N, Harvey M, Gagne B, Shink E, Tremblay M, Raymond C, Labbe M, Villeneuve A, Rochette D, Bordeleau L et al (2006) Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 141B(4):374\u2013382. https:\/\/doi.org\/10.1002\/ajmg.b.30303","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2","key":"9902_CR55","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000515130","volume":"28","author":"S Silberstein","year":"2021","unstructured":"Silberstein S, Liberman AC, Dos Santos Claro PA, Ugo MB, Deussing JM, Arzt E (2021) Stress-related brain neuroinflammation impact in depression: role of the corticotropin-releasing hormone system and P2X7 receptor. NeuroImmunoModulation 28(2):52\u201360. https:\/\/doi.org\/10.1159\/000515130","journal-title":"NeuroImmunoModulation"},{"issue":"14","key":"9902_CR56","doi-asserted-by":"publisher","first-page":"4005","DOI":"10.7150\/ijbs.59032","volume":"17","author":"X Liu","year":"2021","unstructured":"Liu X, Xie Z, Li S, He J, Cao S, Xiao Z (2021) PRG-1 relieves pain and depressive-like behaviors in rats of bone cancer pain by regulation of dendritic spine in hippocampus. Int J Biol Sci 17(14):4005\u20134020. https:\/\/doi.org\/10.7150\/ijbs.59032","journal-title":"Int J Biol Sci"},{"key":"9902_CR57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13578-020-00388-1","volume":"10","author":"D Wang","year":"2020","unstructured":"Wang D, Wang H, Gao H, Zhang H, Zhang H, Wang Q, Sun Z (2020) P2X7 receptor mediates NLRP3 inflammasome activation in depression and diabetes. Cell Biosci 10:28. https:\/\/doi.org\/10.1186\/s13578-020-00388-1","journal-title":"Cell Biosci"},{"issue":"4","key":"9902_CR58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.pain.2014.01.011","volume":"155","author":"ZX Huang","year":"2014","unstructured":"Huang ZX, Lu ZJ, Ma WQ, Wu FX, Zhang YQ, Yu WF, Zhao ZQ (2014) Involvement of RVM-expressed P2X7 receptor in bone cancer pain: mechanism of descending facilitation. Pain 155(4):783\u2013791. https:\/\/doi.org\/10.1016\/j.pain.2014.01.011","journal-title":"Pain"},{"key":"9902_CR59","doi-asserted-by":"publisher","unstructured":"Koyama R, Iwata K, Hayashi Y, Hitomi S, Shibuta I, Furukawa A, Asano S, Kaneko T, Yonehara Y, Shinoda M (2021) Pannexin 1-mediated ATP signaling in the trigeminal spinal subnucleus caudalis is involved in tongue cancer pain. Int J Mol Sci 22(21):https:\/\/doi.org\/10.3390\/ijms222111404","DOI":"10.3390\/ijms222111404"},{"key":"9902_CR60","doi-asserted-by":"publisher","first-page":"CD012592","DOI":"10.1002\/14651858.CD012592.pub2","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA (2017) Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev 7:CD012592. https:\/\/doi.org\/10.1002\/14651858.CD012592.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"9902_CR61","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s40263-019-00660-0","volume":"33","author":"S Mercadante","year":"2019","unstructured":"Mercadante S, Arcuri E, Santoni A (2019) Opioid-induced tolerance and hyperalgesia. CNS Drugs 33(10):943\u2013955. https:\/\/doi.org\/10.1007\/s40263-019-00660-0","journal-title":"CNS Drugs"},{"key":"9902_CR62","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2147\/JIR.S266995","volume":"13","author":"H Wang","year":"2020","unstructured":"Wang H, Zhang Y, Ma X, Wang W, Xu X, Huang M, Xu L, Shi H, Yuan T, Jiang W et al (2020) Spinal TLR4\/P2X7 receptor-dependent NLRP3 inflammasome activation contributes to the development of tolerance to morphine-induced antinociception. J Inflamm Res 13:571\u2013582. https:\/\/doi.org\/10.2147\/JIR.S266995","journal-title":"J Inflamm Res"},{"issue":"7","key":"9902_CR63","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.bbi.2010.06.001","volume":"24","author":"YX Chu","year":"2010","unstructured":"Chu YX, Zhang Y, Zhang YQ, Zhao ZQ (2010) Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses. Brain Behav Immun 24(7):1176\u20131189. https:\/\/doi.org\/10.1016\/j.bbi.2010.06.001","journal-title":"Brain Behav Immun"},{"key":"9902_CR64","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pbb.2015.06.002","volume":"135","author":"Z Xiao","year":"2015","unstructured":"Xiao Z, Li YY, Sun MJ (2015) Activation of P2X7 receptors in the midbrain periaqueductal gray of rats facilitates morphine tolerance. Pharmacol Biochem Behav 135:145\u2013153. https:\/\/doi.org\/10.1016\/j.pbb.2015.06.002","journal-title":"Pharmacol Biochem Behav"},{"issue":"10","key":"9902_CR65","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jpain.2012.06.007","volume":"13","author":"ML Chen","year":"2012","unstructured":"Chen ML, Cao H, Chu YX, Cheng LZ, Liang LL, Zhang YQ, Zhao ZQ (2012) Role of P2X7 receptor-mediated IL-18\/IL-18R signaling in morphine tolerance: multiple glial-neuronal dialogues in the rat spinal cord. J Pain 13(10):945\u2013958. https:\/\/doi.org\/10.1016\/j.jpain.2012.06.007","journal-title":"J Pain"},{"key":"9902_CR66","doi-asserted-by":"publisher","unstructured":"Cao S, Xiao Z, Sun M, Li Y (2016) D-serine in the midbrain periaqueductal gray contributes to morphine tolerance in rats. Mol Pain 12https:\/\/doi.org\/10.1177\/1744806916646786","DOI":"10.1177\/1744806916646786"},{"issue":"2","key":"9902_CR67","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00520-014-2379-9","volume":"23","author":"M Grant","year":"2015","unstructured":"Grant M, Ugalde A, Vafiadis P, Philip J (2015) Exploring the myths of morphine in cancer: views of the general practice population. Support Care Cancer 23(2):483\u2013489. https:\/\/doi.org\/10.1007\/s00520-014-2379-9","journal-title":"Support Care Cancer"},{"key":"9902_CR68","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/bs.pmch.2019.11.002","volume":"59","author":"CF Gelin","year":"2020","unstructured":"Gelin CF, Bhattacharya A, Letavic MA (2020) P2X7 receptor antagonists for the treatment of systemic inflammatory disorders. Prog Med Chem 59:63\u201399. https:\/\/doi.org\/10.1016\/bs.pmch.2019.11.002","journal-title":"Prog Med Chem"},{"key":"9902_CR69","doi-asserted-by":"publisher","unstructured":"Custer EE, Knott TK, Ortiz-Miranda S, Lemos JR (2018) Effects of calcium and sodium on ATP-induced vasopressin release from rat isolated neurohypophysial terminals. J Neuroendocrinol e12605. https:\/\/doi.org\/10.1111\/jne.12605","DOI":"10.1111\/jne.12605"},{"issue":"11","key":"9902_CR70","doi-asserted-by":"publisher","first-page":"13009","DOI":"10.3390\/molecules171113009","volume":"17","author":"R Faria","year":"2012","unstructured":"Faria R, Ferreira L, Bezerra R, Frutuoso V, Alves L (2012) Action of natural products on p2 receptors: a reinvented era for drug discovery. Molecules 17(11):13009\u201313025. https:\/\/doi.org\/10.3390\/molecules171113009","journal-title":"Molecules"},{"issue":"7","key":"9902_CR71","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/carcin\/bgt099","volume":"34","author":"B Jelassi","year":"2013","unstructured":"Jelassi B, Anchelin M, Chamouton J, Cayuela ML, Clarysse L, Li J, Gore J, Jiang LH, Roger S (2013) Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors. Carcinogenesis 34(7):1487\u20131496. https:\/\/doi.org\/10.1093\/carcin\/bgt099","journal-title":"Carcinogenesis"},{"issue":"5","key":"9902_CR72","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/j.1476-5381.2011.01254.x","volume":"163","author":"C Marques-da-Silva","year":"2011","unstructured":"Marques-da-Silva C, Chaves MM, Castro NG, Coutinho-Silva R, Guimaraes MZ (2011) Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action. Br J Pharmacol 163(5):912\u2013926. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01254.x","journal-title":"Br J Pharmacol"},{"issue":"1","key":"9902_CR73","first-page":"45","volume":"12","author":"Y Liu","year":"2020","unstructured":"Liu Y, Wu Y, Gu S, Yin Q, Li H, Wang J, Geng D, Xu Y (2020) The P2X7 receptor (P2X7R)-specific antagonist A804598 inhibits inflammatory reaction in human fibroblast-like synoviocytes. Am J Transl Res 12(1):45\u201353","journal-title":"Am J Transl Res"},{"issue":"1","key":"9902_CR74","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12974-017-0980-9","volume":"14","author":"W Jiang","year":"2017","unstructured":"Jiang W, Li M, He F, Zhou S, Zhu L (2017) Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice. J Neuroinflammation 14(1):207. https:\/\/doi.org\/10.1186\/s12974-017-0980-9","journal-title":"J Neuroinflammation"},{"issue":"19","key":"9902_CR75","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1111\/bph.14787","volume":"176","author":"S Rosli","year":"2019","unstructured":"Rosli S, Kirby FJ, Lawlor KE, Rainczuk K, Drummond GR, Mansell A, Tate MD (2019) Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection. Br J Pharmacol 176(19):3834\u20133844. https:\/\/doi.org\/10.1111\/bph.14787","journal-title":"Br J Pharmacol"},{"issue":"1","key":"9902_CR76","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41598-017-00732-5","volume":"7","author":"RC Allsopp","year":"2017","unstructured":"Allsopp RC, Dayl S, Schmid R, Evans RJ (2017) Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120. Sci Rep 7(1):725. https:\/\/doi.org\/10.1038\/s41598-017-00732-5","journal-title":"Sci Rep"},{"key":"9902_CR77","doi-asserted-by":"publisher","first-page":"695041","DOI":"10.3389\/fcell.2021.695041","volume":"9","author":"Z Li","year":"2021","unstructured":"Li Z, Huang Z, Zhang H, Lu J, Wei Y, Yang Y, Bai L (2021) IRE1-mTOR-PERK axis coordinates autophagy and ER stress-apoptosis induced by P2X7-mediated Ca(2+) influx in osteoarthritis. Front Cell Dev Biol 9:695041. https:\/\/doi.org\/10.3389\/fcell.2021.695041","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"9902_CR78","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1007\/s11010-021-04169-3","volume":"476","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhang S, Wu Y, Wang J (2021) P2X7 receptor antagonist BBG inhibits endoplasmic reticulum stress and pyroptosis to alleviate postherpetic neuralgia. Mol Cell Biochem 476(9):3461\u20133468. https:\/\/doi.org\/10.1007\/s11010-021-04169-3","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"9902_CR79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/13880209.2013.810648","volume":"52","author":"S Zhu","year":"2014","unstructured":"Zhu S, Wang Y, Wang X, Li J, Hu F (2014) Emodin inhibits ATP-induced IL-1beta secretion, ROS production and phagocytosis attenuation in rat peritoneal macrophages via antagonizing P2X(7) receptor. Pharm Biol 52(1):51\u201357. https:\/\/doi.org\/10.3109\/13880209.2013.810648","journal-title":"Pharm Biol"},{"issue":"3","key":"9902_CR80","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","volume":"45","author":"YY Leung","year":"2015","unstructured":"Leung YY, Yao Hui LL, Kraus VB (2015) Colchicine\u2013update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum 45(3):341\u2013350. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.013","journal-title":"Semin Arthritis Rheum"},{"key":"9902_CR81","doi-asserted-by":"publisher","first-page":"174480691880303","DOI":"10.1177\/1744806918803039","volume":"14","author":"P Li","year":"2018","unstructured":"Li P, Zhang Q, Xiao Z, Yu S, Yan Y, Qin Y (2018) Activation of the P2X7 receptor in midbrain periaqueductal gray participates in the analgesic effect of tramadol in bone cancer pain rats. Mol Pain 14:1744806918803039. https:\/\/doi.org\/10.1177\/1744806918803039","journal-title":"Mol Pain"},{"issue":"1","key":"9902_CR82","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-017-0904-8","volume":"14","author":"Y He","year":"2017","unstructured":"He Y, Taylor N, Fourgeaud L, Bhattacharya A (2017) The role of microglial P2X7: modulation of cell death and cytokine release. J Neuroinflammation 14(1):135. https:\/\/doi.org\/10.1186\/s12974-017-0904-8","journal-title":"J Neuroinflammation"},{"key":"9902_CR83","doi-asserted-by":"publisher","unstructured":"Brisson L, Chadet S, Lopez-Charcas O, Jelassi B, Ternant D, Chamouton J, Lerondel S, Le Pape A, Couillin I, Gombault A et al (2020) P2X7 receptor promotes mouse mammary cancer cell invasiveness and tumour progression, and is a target for anticancer treatment. Cancers (Basel) 12 (9):https:\/\/doi.org\/10.3390\/cancers12092342","DOI":"10.3390\/cancers12092342"},{"key":"9902_CR84","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neuropharm.2013.07.027","volume":"75","author":"C Hempel","year":"2013","unstructured":"Hempel C, Norenberg W, Sobottka H, Urban N, Nicke A, Fischer W, Schaefer M (2013) The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor. Neuropharmacology 75:365\u2013379. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.07.027","journal-title":"Neuropharmacology"},{"issue":"16","key":"9902_CR85","doi-asserted-by":"publisher","first-page":"3164","DOI":"10.1016\/j.bmcl.2015.06.001","volume":"25","author":"EA Caseley","year":"2015","unstructured":"Caseley EA, Muench SP, Baldwin SA, Simmons K, Fishwick CW, Jiang LH (2015) Docking of competitive inhibitors to the P2X7 receptor family reveals key differences responsible for changes in response between rat and human. Bioorg Med Chem Lett 25(16):3164\u20133167. https:\/\/doi.org\/10.1016\/j.bmcl.2015.06.001","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"9902_CR86","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1021\/jm021049d","volume":"46","author":"PG Baraldi","year":"2003","unstructured":"Baraldi PG, del Carmen NM, Morelli A, Falzoni S, Di Virgilio F, Romagnoli R (2003) Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor. J Med Chem 46(8):1318\u20131329. https:\/\/doi.org\/10.1021\/jm021049d","journal-title":"J Med Chem"},{"issue":"2","key":"9902_CR87","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1124\/jpet.105.092460","volume":"315","author":"MI Damaj","year":"2005","unstructured":"Damaj MI (2005) Calcium-acting drugs modulate expression and development of chronic tolerance to nicotine-induced antinociception in mice. J Pharmacol Exp Ther 315(2):959\u2013964. https:\/\/doi.org\/10.1124\/jpet.105.092460","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-022-09902-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-022-09902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T08:27:12Z","timestamp":1686126432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-022-09902-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["9902"],"URL":"https:\/\/doi.org\/10.1007\/s11302-022-09902-1","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"25 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. All authors have read this manuscript and agree to publish.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to the publishing policy.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}